Table of Contents Table of Contents
Previous Page  291 / 453 Next Page
Information
Show Menu
Previous Page 291 / 453 Next Page
Page Background

QIAGEN

mericon

STEC Workflow Collaborative Study Protocol

May 2016

DRAFT

5

1.3

Co-Study Directors for the Collaborative Study

Marcia Armstrong

QIAGEN, Inc.

Global Scientific Affairs Manager

Applied Testing – Food Safety

19300 Germantown Road

Germantown, MD 20874

Marcia.armstrong@qiagen.com

617-852-8131

Erin Crowley

Microbiology R&D Supervisor

Q Laboratories, Inc.

1400 Harrison Ave.

Cincinnati, OH 45214

ecrowley@qlaboratories.com

513-471-1300

2.0

Collaborators

A minimum of 10 valid data sets are needed for the successful completion of this study, so 12-15

collaborators will be solicited to participate. Qualified analysts, familiar with the

mericon

® Pathogen

Detection System, will act as collaborators. All collaborators have been, or will be, thoroughly trained by

a QIAGEN representative on the use of the

mericon

® System (QIAsymphony SP/AS and Rotor-Gene Q).

QLabs will provide 3 collaborators. Additional collaborator sites could include Vanguard, FSNS, Covance,

Aemtek, Microbac, Silliker, Tyson or Marshfield. Each site must have a large Stomacher or similar

homogenization equipment and preferably will be able to confirm all test portion sets at that site. In the

event a site cannot accommodate the confirmation of all test portion sets, they must be able to ship

infectious samples to QLabs for confirmation. QLabs can accommodate the confirmation of up to 3 test

portion sets in addition to the 3 test portions sets from their own laboratory. A sample letter to

collaborators can be found in Appendix 8.1. This letter will be sent to each collaborator prior to the start

of the study. In addition, a conference call will be held with collaborators to review the study protocol in

detail and answer any questions before the start of the study.

3.0

Collaborative Study Design

3.1

The study will include 4-5 test sites, with no more than 3 collaborators at each site. The

collaborators at each site will share the use of a

mericon

® system (QIAsymphony SP/AS

and Rotor-Gene Q). The three collaborators may be three analysts employed at that

site, but working independently.

3.2

The

mericon

E. coli O157 Screen Plus and

mericon

E. coli STEC O-Type methods will be

validated together as one workflow and will comprise one Official Method. The method

will include both manual and automated sample prep and assay setup options and will

be applicable to ground beef and beef trim. Spinach will not be included in the OMA

claim.

3.3

One matrixis proposed. Fresh raw ground beef (325 g test portion size) artificially

inoculated with

E. coli

O157:H7 will be analyzed in a paired study design by the

mericon

workflow and the FSIS MLG 5.09 reference method.

OMAMAN-36 B : Collaborative Study Protocol

For ERP Use Only

January 2017

AOAC Research Institute

Expert Review Pan l Use Only